BlackRock Japan’s Anika Therapeutics ANIK Stock Holding History

BlackRock Japan’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,250	Closed	-$41K	–	1266
2015 Q2	$41K	Sell	1,250 -3,560	-74%	-$127K	﹤0.01%	1105
2015 Q1	$198K	Hold	4,810	–	–	﹤0.01%	875
2014 Q4	$196K	Sell	4,810 -413	-8%	-$16.1K	﹤0.01%	881
2014 Q3	$191K	Buy	5,223 +2,542	+95%	+$110K	﹤0.01%	855
2014 Q2	$124K	Buy	+2,681	New	+$119K	﹤0.01%	909
2013 Q4	–	Sell	-1,803	Closed	-$43K	–	1341
2013 Q3	$43K	Buy	+1,803	New	+$40.5K	﹤0.01%	1149

Other funds holding ANIK

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

LCP

Lombardia Capital Partners Pasadena, California $110M AUM 13.11% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CSC

Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

BlackRock Japan's ANIK Position: Q3 2015 in Review

BlackRock Japan sold out of Anika Therapeutics (ANIK) in Q3 2015, closing a stake of 1,250 shares — an estimated $41K sold.

BlackRock Japan first reported a position in ANIK in Q3 2013 and held it in 6 quarters. The position peaked at $198K in Q1 2015. 138 funds tracked by Wall St. Rank hold ANIK as of Q3 2015.

BlackRock Japan reported no remaining Anika Therapeutics position as of Q3 2015 after selling out during the quarter.
BlackRock Japan sold 1,250 Anika Therapeutics shares in Q3 2015, an estimated $41K.
BlackRock Japan first reported a position in Anika Therapeutics in Q3 2013 and held it in 6 quarters.
BlackRock Japan's Anika Therapeutics position peaked at $198K in Q1 2015.
138 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2015.

Based on BlackRock Japan's 13F filing for Q3 2015, filed 13 Nov 2015.